Rhythm Pharmaceuticals (RYTM)
(Delayed Data from NSDQ)
$53.64 USD
+0.47 (0.88%)
Updated Sep 18, 2024 03:59 PM ET
After-Market: $53.70 +0.06 (0.11%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth D Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/05/2024
Time: -- |
9/2024 | $-0.81 | 0.00% |
Earnings Summary
For their last quarter, Rhythm Pharmaceuticals (RYTM) reported earnings of -$0.55 per share, beating the Zacks Consensus Estimate of $-0.70 per share. This reflects a positive earnings surprise of 21.43%. Look out for RYTM's next earnings release expected on November 05, 2024. For the next earning release, we expect the company to report earnings of -$0.81 per share, reflecting a year-over-year decrease of 6.58%.
Earnings History
Price & Consensus
Zacks News for RYTM
Biotech Stock Roundup: REGN's Drug Approval, LXRX, RYTM Stocks Gain on Update & More
RYTM: What are Zacks experts saying now?
Zacks Private Portfolio Services